Quantcast

Latest FDA Stories

2014-05-23 23:07:54

On May 16, the FDA announced that certain Vental Resuscitator Bags are recalled due to possible health risk. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) May 23, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for resuscitator bags. The FDA announced on May 16, that certain Ventlab...

2014-05-23 20:21:52

GERMANTOWN, Maryland and HILDEN, Germany, May 23, 2014 /PRNewswire/ -- - Clinically proven companion diagnostic gains U.S. approval to guide use of Amgen's Vectibix(R) (panitumumab) in treatment of metastatic colorectal cancer - FDA approval (PMA) of therascreen KRAS RGQ PCR Kit for Vectibix expands QIAGEN's leadership in molecular companion diagnostics for personalized healthcare - QIAGEN driving the adoption of molecular tests...

2014-05-23 16:24:12

Vectibix is the First and Only Biologic to Offer Significant Survival Benefit as a First-Line Treatment with FOLFOX Chemotherapy for Patients with Wild-Type KRAS Metastatic Colorectal Cancer THOUSAND OAKS, Calif., May 23, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Vectibix(® )(panitumumab) for use in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, as first-line treatment in patients with...

2014-05-23 08:24:15

SpringTMS is the first medical device available to patients in the United States to relieve the pain caused by migraine headaches that are preceded by an aura BALTIMORE, May 23, 2014 /PRNewswire/ -- eNeura, Inc., a privately held medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SpringTMS(®) migraine treatment device. SpringTMS is the first medical device available to patients in the United States for the...

2014-05-23 08:24:08

BOSTON, Mass., May 23, 2014 /PRNewswire/ -- AZTherapies, Inc. a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, announced that it has received notice from FDA that it may proceed with the Phase III clinical study submitted in its IND application. This study is for its lead program, ALZT-OP1, a novel combination therapy for the prevention and treatment of early Alzheimer's disease. ALZT-OP1 is a...

2014-05-22 23:15:44

“Those with herpes zoster had a higher incidence of developing major depression,” according to a study published on May 7, 2014 in Psychosomatic Medicine (1).” polyDNA reviews the study and recommends that individuals take Gene-Eden-Vir and Novirin against the latent herpes zoster virus. Rochester, NY (PRWEB) May 22, 2014 The presence of the varicella zoster virus (VZV or herpes zoster virus), which causes chickenpox and shingles, has also been linked to the development of major...

2014-05-22 23:12:39

On May 16, the FDA notified consumers not to purchase or use MV5 Days because it contains undeclared drug ingredient. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) May 22, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for MV5 Days. The FDA notified consumers on May 16, not to purchase...

2014-05-22 16:26:56

Addresses critical unmet needs in blood banking and transfusion medicine - a fast, FDA-approved way to generate critical genetic matching information necessary to: NORCROSS, Ga., May 22, 2014 /PRNewswire/ -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company's PreciseType HEA test. The PreciseType HEA test is the first FDA-approved molecular assay designed...

sugar substitute advantame
2014-05-22 05:40:23

April Flowers for redOrbit.com - Your Universe Online The US Food and Drug Administration (FDA) announced this week that a new food additive, Advantame, has been approved. Advantame, the sixth high-intensity sweetener approved by the FDA, has been rated as safe for use as a general-purpose sweetener and flavor enhancer in food, except meat and poultry. Before being marketed in the US, all new food additives must be approved by the FDA. Advantame, which does not have a brand name yet,...

2014-05-21 23:15:50

“The HZ (herpes zoster/shingles) cohort showed a significantly higher cumulative incidence rate of developing CFS (chronic fatigue syndrome),”according to a study published on May 1, 2014 in The European Journal of Clinical Microbiology & Infectious Diseases (1). polyDNA reviews the study and recommends that patients with severe fatigue talk to their doctors about Gene-Eden-VIR and Novirin. Rochester, NY (PRWEB) May 21, 2014 Many studies found a link between Chronic Fatigue...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.